Leadership Update New CEO Erica Jordan appointed July 12, 2026, signaling potential strategic shifts and renewed emphasis on growth and strategic partnerships that could open new enterprise sales conversations and channel opportunities.

Regulatory Progress Active engagement with CMS to obtain temporary codes accelerating reimbursement for XTRAC excimer laser treatment, presenting a sales lead path to clinics seeking faster payer approval and expanded patient access.

Financial Momentum Recent financing closes and multi-million revenue range indicate ongoing capital availability and validation of demand, suggesting capacity for sales expansion, larger deal sizes, and faster sales cycles with performance milestones.

In-market Expansion Strategic conference appearances and investor presentations with ongoing visibility into corporate roadmap create opportunities to connect with dermatology clinics, integrated delivery networks, and specialty distributors seeking advanced dermatologic solutions.

Competitive Positioning Litigation context and anticompetitive claims highlight a competitive landscape; position STRATA as a differentiated technology provider with compelling in-office and reimbursement advantages to win share against peers.